Gyre Therapeutics, Inc.

GYRE ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2015

Total Assets: $69.5M

Liabilities Breakdown FY2015

Total Liabilities: $38.1M